Author:
Delforge Michel,Patel Krina,Eliason Laurie,Dhanda Devender,Shi Ling,Guo Shien,Marshall Thomas S,Arnulf Bertrand,Cavo Michele,Nooka Ajay,Manier Salomon,Callander Natalie,Giralt Sergio,Einsele Hermann,Ailawadhi Sikander,Popa McKiver Mihaela,Cook Mark,Rodríguez-Otero Paula
Reference30 articles.
1. Health-related quality of life of patients with multiple myeloma treated in routine clinical practice in France;Despiegel;Clin Lymphoma Myeloma Leuk,2019
2. Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma;Kamal;Support Care Cancer,2021
3. Health-related quality of life in heavily pre-treated and renally impaired patients with relapsed/refractory multiple myeloma receiving isatuximab plus pomalidomide and dexamethasone: the ICARIA-MM study;Dimopoulos;EHA Library,2020
4. Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study);Moreau;Leukemia,2019
5. Patient-reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled PANARAMA-1 trial;Richardson;Br J Haematol,2018
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献